Eliciting patient preferences for hormonal therapy options in the treatment of metastatic prostate cancer

被引：0
作者：
A Lloyd
D Penson
S Dewilde
L Kleinman
机构：
[1] United BioSource Corporation,Departments of Urology and Preventive Medicine
[2] Keck School of Medicine,undefined
[3] University of Southern California,undefined
[4] United BioSource Corporation,undefined
[5] United BioSource Corporation,undefined
来源：
Prostate Cancer and Prostatic Diseases | 2008年 / 11卷
关键词：
hormone treatment; preferences; willingness to pay;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Treatment choices for metastatic prostate cancer are complex and can involve men balancing survival versus quality of life. The present study aims to elicit patient preferences with respect to the attributes of treatments for metastatic prostate cancer through a discrete choice experiment (DCE) questionnaire. Men with recently diagnosed localized prostate cancer were asked to envisage that they had metastatic disease when completing a survey. As expected, men with prostate cancer placed considerable importance on gains in survival; however, avoiding side effects of treatment was also clearly important. Survival gains should be considered alongside side effects when discussing treatment options in metastatic disease.
引用
收藏
页码：153 / 159
页数：6
相关论文
共 54 条
  • [1] Schelhammer PF(1997)Clinical benefits of bicalutamide compared with flutamide in combined androgen blockade for patients with advance prostatic carcinoma: final repot of a double blind randomized multicenter trial Urology 50 330-336
  • [2] Sharifi R(2002)An evaluation of bicalutamide in the treatment of prostate cancer Expert Opin Pharmacother 3 1313-1328
  • [3] Block N(2005)Preferences of healthy men for two different endocrine treatment options offered for locally advanced prostate cancer Curr Med Res Opinion 21 1329-1335
  • [4] Soloway MS(2004)Patients’ preferences for the management of non-metastatic prostate cancer: discrete choice experiment BMJ 328 382-1533
  • [5] Venner PM(2000)Using conjoint analysis to elicit preferences in health care BMJ 320 1530-142
  • [6] Patterson AL(2001)Patient weighting of importance of asthma symptoms Thorax 56 138-1181
  • [7] Schellhammer PF(2005)The importance of drug adverse effects compared with seizure control for people with epilepsy: a discrete choice experiment Pharmacoeconomics 23 1167-151
  • [8] Jenkins V(1998)Maximal androgen blockade: final analysis of EORTC phase III trial 30853. EORTC Genito-Urinary Tract Cancer Cooperative Group and the EORTC Data Center Eur Urol 33 144-37
  • [9] Fallowfield L(2000)Side effects of endocrine treatment and their mechanisms: castration, antiandrogens and estrogens Prostate 10 32-1498
  • [10] Edginton T(2000)Maximum androgen blockade in advanced prostate cancer: an overview of randomised trials Lancet 355 1491-1042
123456